[Immunosuppression with cyclosporin A in high-risk keratoplasties].
It is generally accepted that corneal grafts in hypervascular and sclerosed host corneas have little chance of success. At the end of a three-month postoperative immunosuppression period using the new immunosuppressant Cyclosporin A, full incorporation of transplants was achieved in 10 out of 11 high-risk patients. Patients were observed over a period of between 3 and 15 months, the median being 9 months.
D003316:Corneal Diseases / Q000601:surgery*; D016039:Corneal Transplantation; D003524:Cyclosporins / Q000627:therapeutic use*; D006084:Graft Rejection / Q000187:drug effects*; D006801:Humans; D012306:Risk
D003524:Cyclosporins
Immunsuppression mit Cyclosporin A bei Risikokeratoplastiken.